Alnylam Pharmaceuticals (ALNY) Price to Earnings (2009 - 2026)

Alnylam Pharmaceuticals (ALNY) Price to Earnings (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	P/E
1	Oculis Holding AG	65,719.23 Bn	65,718.94 Bn	-	-30.67 Bn
2	Nanobiotix	1,933.82 Bn	1,933.76 Bn	-	-70,009.43
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-	-32,669.10
4	BeOne Medicines	471.85 Bn	467.06 Bn	1.35 Bn	919.76
5	Vertex Pharmaceuticals	122.29 Bn	115.04 Bn	2.59 Bn	28.19
6	Regeneron Pharmaceuticals	70.04 Bn	61.28 Bn	3.31 Bn	15.83
7	Belite Bio	62.06 Bn	62.06 Bn	-	365.08 Bn
8	Argenx Se	55.78 Bn	50.60 Bn	1.41 Bn	32.52
9	Alnylam Pharmaceuticals	37.47 Bn	34.47 Bn	959.66 Mn	68.89
10	Revolution Medicines	37.17 Bn	37.17 Bn	-	-27.10

Download Data